Alan Spatz
Impact in
- Oncology top 0.5%
- Cutaneous Melanoma Detection and Management
- Cancer Immunotherapy and Biomarkers
- Dermatology top 0.5%
- Chemotherapy-related skin toxicity
Papers in
- Oncology 100
- Cutaneous Melanoma Detection and Management 69
- Cancer Immunotherapy and Biomarkers 16
-
- Cancer Genomics and Diagnostics 12
- Co-authors
- Alexander M.M. Eggermont (28 shared papers)Caroline Robert (20 shared papers)Janine Wechsler (7 shared papers)Raymond L. Barnhill (11 shared papers)Bernard J. Escudier (5 shared papers)Stefan Suciu (15 shared papers)Alessandro Testori (14 shared papers)Wim H.J. Kruit (12 shared papers)
- Journals
- European Journal of Cancer (17 papers)Journal of Clinical Oncology (8 papers)Melanoma Research (6 papers)Journal of Thoracic Oncology (6 papers)Molecular Oncology (5 papers)
- Partner nations
- FranceCanadaNetherlands
In The Last Decade
Alan Spatz
203 papers receiving 10.6k citations
Alan Spatz's Hit Papers
Peers
Comparison fields: 5 of 149
- Oncology 4.6k
- Dermatology 811
- Cancer Research 692
- Immunology 896
- Molecular Biology 2.8k
Countries citing papers authored by Alan Spatz
This map shows the geographic impact of Alan Spatz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Spatz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Spatz more than expected).
Fields of papers citing papers by Alan Spatz
This network shows the impact of papers produced by Alan Spatz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Spatz. The network helps show where Alan Spatz may publish in the future.
Co-authors
The 25 scholars most cited alongside Alan Spatz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 211 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial Hit paper breakdown → | 2005 | 1127 |
| 2 | 2008 | 502 | |
| 3 | 2013 | 457 | |
| 4 | Cutaneous side-effects of kinase inhibitors and blocking antibodies Hit paper breakdown → | 2005 | 440 |
| 5 | 2006 | 417 | |
| 6 | 2004 | 243 | |
| 7 | 2009 | 238 | |
| 8 | 2012 | 230 | |
| 9 | 2007 | 228 | |
| 10 | 2013 | 191 | |
| 11 | 2008 | 187 | |
| 12 | 2012 | 183 | |
| 13 | 2011 | 170 | |
| 14 | 1999 | 167 | |
| 15 | 2011 | 166 | |
| 16 | 2011 | 160 | |
| 17 | 2003 | 159 | |
| 18 | 2009 | 150 | |
| 19 | 2004 | 147 | |
| 20 | 2014 | 146 |
About Alan Spatz
Alan Spatz is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Dermatology and Immunology, having authored 211 papers that have together received 11k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (69 papers), Cancer Immunotherapy and Biomarkers (16 papers), Lung Cancer Treatments and Mutations (16 papers), Melanoma and MAPK Pathways (16 papers), Cancer Genomics and Diagnostics (12 papers), Ethics in Clinical Research (9 papers), Chemotherapy-related skin toxicity (8 papers) and BRCA gene mutations in cancer (8 papers). The work is most often cited by research in Oncology (4.6k citations), Dermatology (811 citations), Cancer Research (692 citations), Immunology (896 citations) and Molecular Biology (2.8k citations). Alan Spatz has collaborated with scholars based in France, Canada and Netherlands. Frequent co-authors include Alexander M.M. Eggermont, Caroline Robert, Janine Wechsler, Raymond L. Barnhill, Bernard J. Escudier, Stefan Suciu, Alessandro Testori, Wim H.J. Kruit, Ulrich Keilholz and Dirk Schadendorf. Their work appears in journals such as European Journal of Cancer, Journal of Clinical Oncology, Melanoma Research, Journal of Thoracic Oncology and Molecular Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.